AG真人官方

STOCK TITAN

AG真人官方 Labs, Actual Decisions With Actionable Six Sigma Metrics

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

QuidelOrtho (NASDAQ: QDEL) has announced a featured session at the upcoming Association for Diagnostics & Laboratory Medicine (ADLM) meeting, focusing on Six Sigma metrics in laboratory performance. The session, titled "AG真人官方 Labs, AG真人官方 Decisions with Actionable Six Sigma Metrics," will take place on July 29, 2025 at the McCormick Convention Center in Chicago.

The panel discussion will feature experts including Dr. Jared Jaeger as moderator, along with distinguished professionals from the University of Florida PathLab, St. Peter's University Hospital, and UHS Hospitals. The session will explore how QuidelOrtho's Six Sigma tools and real-world laboratory data can be utilized to enhance quality outcomes in clinical settings.

QuidelOrtho (NASDAQ: QDEL) ha annunciato una sessione speciale al prossimo incontro dell'Association for Diagnostics & Laboratory Medicine (ADLM), incentrata sulle metriche Six Sigma nella performance di laboratorio. La sessione, intitolata "Laboratori AG真人官方i, Decisioni AG真人官方i con Metriche Six Sigma Utili", si terr脿 il 29 luglio 2025 presso il McCormick Convention Center di Chicago.

Il panel includer脿 esperti come il dott. Jared Jaeger in qualit脿 di moderatore, insieme a professionisti di rilievo provenienti dall'University of Florida PathLab, dal St. Peter's University Hospital e dagli UHS Hospitals. La sessione analizzer脿 come gli strumenti Six Sigma di QuidelOrtho e i dati di laboratorio reali possano essere impiegati per migliorare i risultati qualitativi negli ambienti clinici.

QuidelOrtho (NASDAQ: QDEL) ha anunciado una sesi贸n destacada en la pr贸xima reuni贸n de la Association for Diagnostics & Laboratory Medicine (ADLM), centrada en las m茅tricas Six Sigma en el desempe帽o de laboratorio. La sesi贸n, titulada "Laboratorios AG真人官方es, Decisiones AG真人官方es con M茅tricas Six Sigma Accionables", se llevar谩 a cabo el 29 de julio de 2025 en el McCormick Convention Center en Chicago.

La mesa redonda contar谩 con expertos, incluyendo al Dr. Jared Jaeger como moderador, junto con profesionales destacados de University of Florida PathLab, St. Peter's University Hospital y UHS Hospitals. La sesi贸n explorar谩 c贸mo las herramientas Six Sigma de QuidelOrtho y los datos reales de laboratorio pueden utilizarse para mejorar los resultados de calidad en entornos cl铆nicos.

QuidelOrtho (NASDAQ: QDEL)電� 雼り皜鞓る姅 歆勲嫧 氚� 鞁ろ棙鞁� 鞚橅暀 順戫殞(ADLM) 須岇潣鞐愳劀 鞁ろ棙鞁� 靹标臣鞚� 鞁濎姢 鞁滉犯毵� 歆響滌棎 齑堨爯鞚� 毵烄稑 韸闺硠 靹胳厴鞚� 氚滍憸頄堨姷雼堧嫟. "鞁れ牅 鞁ろ棙鞁�, 鞁ろ枆 臧電ロ暅 鞁濎姢 鞁滉犯毵� 歆響滊 鞁れ鞝� 瓴办爼"鞚措澕電� 鞝滊鞚� 鞚� 靹胳厴鞚 2025雲� 7鞗� 29鞚� 鞁滌勾瓿� 毵レ綌氙� 旎菠靺� 靹柬劙鞐愳劀 鞐措Υ 鞓堨爼鞛呺媹雼�.

韺剱 韱犽鞐愲姅 臁办爼鞛愲靹� Jared Jaeger 氚曥偓毳� 牍勲’頃� 頂岆毽嫟 雽頃欔祼 PathLab, 靹胳澑韸� 頂柬劙鞀� 雽頃� 氤戩洂, UHS 氤戩洂鞚� 鞝氇呿暅 鞝勲臧霌れ澊 彀胳棳頃╇媹雼�. 鞚� 靹胳厴鞐愳劀電� QuidelOrtho鞚� 鞁濎姢 鞁滉犯毵� 霃勱惮鞕 鞁れ牅 鞁ろ棙鞁� 雿办澊韯半ゼ 頇滌毄頃橃棳 鞛勳儊 頇橁步鞐愳劀 頀堨 靹标臣毳� 頄レ儊鞁滍偆電� 氚╇矔鞚� 韮愱惮頃� 瓴冹瀰雼堧嫟.

QuidelOrtho (NASDAQ: QDEL) a annonc茅 une session sp茅ciale lors de la prochaine r茅union de l'Association for Diagnostics & Laboratory Medicine (ADLM), ax茅e sur les indicateurs Six Sigma dans la performance des laboratoires. La session, intitul茅e "Laboratoires R茅els, D茅cisions R茅elles avec des Indicateurs Six Sigma Exploitables", se tiendra le 29 juillet 2025 au McCormick Convention Center de Chicago.

La table ronde r茅unira des experts, dont le Dr Jared Jaeger en tant que mod茅rateur, ainsi que des professionnels de renom de l'University of Florida PathLab, de l'h么pital universitaire St. Peter's et des h么pitaux UHS. La session explorera comment les outils Six Sigma de QuidelOrtho et les donn茅es r茅elles des laboratoires peuvent 锚tre utilis茅s pour am茅liorer les r茅sultats qualitatifs en milieu clinique.

QuidelOrtho (NASDAQ: QDEL) hat eine Sonderveranstaltung auf dem bevorstehenden Treffen der Association for Diagnostics & Laboratory Medicine (ADLM) angek眉ndigt, die sich auf Six-Sigma-Kennzahlen zur Laborleistung konzentriert. Die Sitzung mit dem Titel "Echte Labore, echte Entscheidungen mit umsetzbaren Six-Sigma-Kennzahlen" findet am 29. Juli 2025 im McCormick Convention Center in Chicago statt.

Die Podiumsdiskussion wird Experten wie Dr. Jared Jaeger als Moderator sowie angesehene Fachleute von der University of Florida PathLab, dem St. Peter's University Hospital und den UHS Hospitals umfassen. Die Sitzung wird untersuchen, wie QuidelOrthos Six-Sigma-Werkzeuge und echte Labordaten verwendet werden k枚nnen, um die Qualit盲tsresultate in klinischen Umgebungen zu verbessern.

Positive
  • None.
Negative
  • None.

QuidelOrtho Announces Featured ADLM Session

SAN DIEGO, July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

ADLM Session Details:

Session Title:

AG真人官方 Labs, AG真人官方 Decisions with Actionable Six Sigma Metrics

When:

Tuesday, July 29, 2025

Where:

McCormick Convention Center

Chicago, IL

Exhibit Hall, Theater 1

Time:

2:45 p.m. 鈥� 3:45 p.m. CT

Registration:

Space is limited. ADLM attendees can register for the session using
this link:
Media registered for ADLM 鈥� please reach out to Nikki Wheeler to
access the session at [email protected]


AG真人官方 Labs, AG真人官方 Decisions With Actionable Six Sigma Metrics Panelists:

Dr. Jared Jaeger
Clinical Science Liaison
QuidelOrtho
Moderator

Dr. Bremansu Osa-Andrews
Medical Director of Clinical
Chemistry and Clinical Assistant Professor
University of Florida PathLab

Gilles Attipoe
Director of Laboratory Services
St. Peter's University Hospital

Angela Armato
Core Lab Manager
United Health Services and UHS Hospitals

To learn more about Six Sigma and the value of using real-world data listen to聽 In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.

Unable to attend ADLM? Register to watch a recording of the session: .

About QuidelOrtho
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed鈥揻rom home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

[email protected]

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

[email protected]

Cision View original content to download multimedia:

SOURCE QuidelOrtho Corporation

FAQ

When and where is QuidelOrtho's ADLM session on Six Sigma metrics taking place?

The session will be held on Tuesday, July 29, 2025 from 2:45 p.m. to 3:45 p.m. CT at the McCormick Convention Center in Chicago, IL, Exhibit Hall, Theater 1.

Who are the panelists for QuidelOrtho's ADLM Six Sigma metrics session?

The panel includes Dr. Jared Jaeger (Moderator), Dr. Bremansu Osa-Andrews (University of Florida PathLab), Gilles Attipoe (St. Peter's University Hospital), and Angela Armato (UHS Hospitals).

How can I register for QuidelOrtho's ADLM session if I'm unable to attend in person?

You can register to watch a recording of the session through QuidelOrtho's registration link: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.

What is the main focus of QuidelOrtho's ADLM session?

The session focuses on how actionable Six Sigma insights and real laboratory data can be used to improve laboratory performance and drive quality outcomes.
Quidel

NASDAQ:QDEL

QDEL Rankings

QDEL Latest News

QDEL Latest SEC Filings

QDEL Stock Data

1.61B
66.81M
0.92%
114.59%
9.24%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
SAN DIEGO